Two-year clinical follow-up of the FIREHAWK abluminal groove-filled biodegradable polymer sirolimus-

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户：chj0821031

【摘要】

：

Background This article reports the 2-year clinical outcomes of the abtuminal groove-filled biodegradable polymer sirolimus-eluting stent (SES) FIREHAWK (MicroPort Medical,Shanghai,China) compared wit

【作者】

：

Zhao Yelin Xu Bo Yang Yuejin Ma Changsheng Han Yaling Chen Shaoliang Li Hui Zhang Ruiyan Huo Yong Martin B.Leon Gao Runlin

【机构】

：

Fu Wai Hospital National Center for Cardiovascular Diseases,Beijing,China

【出处】

：

第十二届中国介入心脏病学大会(CIT2014)

【发表日期】

：

2014年3期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Performance of 2.25-mm diameter FIREHAWK abluminal groove-filled biodegradable polymer sirolimus-elu

Background Higher rates of adverse cardiac events and restenosis have been observed in patients with small vessel disease.The workhorse sizes of FIREHAWK abluminal groove-filled biodegradable polymer

会议

One-year results of everolimus-eluting stents for treatment of long coronary lesions:a subgroup anal

Background Long coronary lesions remain a higher risk of unfavorable outcomes after percutaneous coronary intervention and the stent length was recognized an independent factor for DES failure.No larg

会议

One-year results of everolimus-eluting stents for treatment of multivessel disease:a subgroup analys

Background The choice of revascularization strategy in multivessel coronary disease remains a critical issue in cardiology.No large-scale clinical study of everolimus-eluting Stents (EES) was conducte

会议

Impact of diabetes status on long-term (6 years) outcomes after percutaneous coronary intervention o

Background Scant data exist regarding the impact of diabetes mellitus (DM) status on percutaneous coronary intervention (PCI) for left main (LM) coronary artery disease.We sought to compare the impact

会议

Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent

Background TARGET Ⅰ randomized controlled trial (RCT) demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was

会议

富马酸喹硫平对精神分裂症急性期兴奋症状疗效的研究

目的评价富马酸喹硫平600 ～ 750mg/d单药治疗精神分裂症急性期兴奋症状的疗效和安全性.方法采用前瞻性、单组、开放性的设计,纳入符合ICD-10诊断标准的精神分裂症急性期患者124例,予喹硫平600～750mg/d单药治疗.观察时间为24周,在基线、治疗第1周末、第8周末及第24周末评估患者的治疗效果及安全性.疗效指标为阳性与阴性症状综合症量表(positive and negative

会议

富马酸喹硫平对精神分裂症急性期阴性症状和抑郁症状的疗效研究

目的评价富马酸喹硫平单药治疗精神分裂症急性期阴性症状和抑郁症状的疗效.方法采用前瞻性、单组、开放性的研究设计.纳入符合ICD-10精神分裂症诊断标准的124例精神分裂症急性期住院患者,予富马酸喹硫平600～750mg/d单药治疗,观察时间为24周,在基线、治疗第1周末、第8周末及第24周末评估患者的治疗效果及安全性.疗效指标为阳性与阴性症状综合征量表(PANSS)评分变化、蒙哥马利抑郁量表(M

会议

Clinical outcomes after percutaneous coronary intervention in acute myocardial infarction due to unp

Background Patients with acute myocardial infarction (AMI) with unprotected left main coronary artery (UPLMCA) as culprit lesion are a high-risk subgroup with a substantial mortality.Primary percutane

会议

Clinical outcomes of overlapping second-generation drug eluting stents in patients with diffuse coro

Background Second-generation drug eluting stents (DSE) associated with reduced major cardiac events compared to first-generation DES.However,limited data exists as to the clinical outcome of overlappi

会议

A comparison of culprit vessel only versus staged percutaneous coronary intervention in ST-segment e

Background ST-segment elevation myocardial infarction (STEMI) patients are often accompanied with multivessel disease.The current guideline recommended treating the culprit vessel at the primary percu

会议

Two-year clinical follow-up of the FIREHAWK abluminal groove-filled biodegradable polymer sirolimus-

与本文相关的学术论文